Valeo Pharma Shareholders Endorse Management
Valeo Pharma Inc (TSE:VPH) has released an update.
TipRanksApr 26 07:10
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
Yahoo FinanceApr 26 05:55
VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE
Yahoo FinanceApr 9 19:00
Stocks in Play: Valeo Pharma Inc.
Baystreet.caMar 22 21:42
Valeo Pharma Reports Q1 Results
Seeking AlphaMar 15 21:39
VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS
Yahoo FinanceMar 15 05:29
VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST
Yahoo FinanceMar 7 20:00
VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP
Yahoo FinanceFeb 3 06:03
VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL YEAR 2023
Yahoo FinanceJan 30 06:48
VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCAST
Yahoo FinanceJan 22 20:00
Analysts Just Shaved Their Valeo Pharma Inc. (TSE:VPH) Forecasts Dramatically
Yahoo FinanceSep 22, 2023 02:15
It's Down 29% But Valeo Pharma Inc. (TSE:VPH) Could Be Riskier Than It Looks
Yahoo FinanceJun 8, 2023 18:01
Valeo Pharma Reports Q2 Results
Seeking AlphaMay 25, 2023 21:32
Valeo Pharma Sees Q2 Revenue Above Estimates
Seeking AlphaMay 25, 2023 19:33
Valeo Pharma to Webcast Live at VirtualInvestorConferences.com March 9th
MONTREAL, March 06, 2023 (GLOBE NEWSWIRE) -- Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF, FSE: VP2)) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Steve Saviuk, CEO, will present live
GlobeNewswireMar 6, 2023 21:36
Valeo Pharma Reports Q4 Results
Seeking AlphaJan 31, 2023 06:31
Great News for Valeo Pharma Inc. (TSE:VPH): Insiders Acquired Stock in Large Numbers Last Year
Yahoo FinanceDec 18, 2022 22:31
Valeo Pharma Raises Q4 Revenue Guidance
Seeking AlphaNov 15, 2022 21:13
Valeo Inks Contract With Veru for COVID-19 Drug Sabizabulin
Valeo Pharma (OTCQB:VPHIF) said it signed a commercial services agreement with Veru for COVID-19 drug sabizabulin in Canada. Sabizabulin is an antiviral and anti-inflammatory drug being developed to t
Seeking AlphaSep 14, 2022 20:20
Valeo Pharma Reports Q3 Results
Valeo Pharma press release (OTCQB:VPHIF): Q3 Revenue of $6.1M beats by $1.41M. Cash and liquidities of $27.7 million as at July 31, 2022
Seeking AlphaSep 14, 2022 05:32
No Data
No Data